This Week: Resveratrol, Lung Ca Screening, Lunesta Dosing
(MedPage Today) -- Health benefits from the red-wine chemical resveratrol appear to have been overblown, lung cancer screening is effective but costly, and low starting doses are now recommended for Lunesta. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 16, 2014 Category: Cardiology Source Type: news

FDA cuts recommended Lunesta dose in half
Lunesta may help you doze off at night, but it's the morning after that has officials concerned -- which is why on Thursday they halved the recommended dosage for the well-known sleep aid. (Source: WDSU.com - Health)
Source: WDSU.com - Health - May 16, 2014 Category: Consumer Health News Source Type: news

Lunesta dose cut in half
Lunesta may help you doze off at night, but it's the morning after that has officials concerned -- which is why on Thursday they halved the recommended dosage for the well-known sleep aid drug. (Source: CNN.com - Health)
Source: CNN.com - Health - May 16, 2014 Category: Consumer Health News Source Type: news

Start Sleep Drug Lunesta at Lower Dose for Safety, FDA Says
Title: Start Sleep Drug Lunesta at Lower Dose for Safety, FDA SaysCategory: Health NewsCreated: 5/15/2014 2:36:00 PMLast Editorial Review: 5/16/2014 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - May 16, 2014 Category: Sleep Medicine Source Type: news

F.D.A. Recommends Lower Dose of the Sleeping Pill Lunesta
The agency recommended a new starting dose of one milligram, down from two milligrams, and told the pill’s manufacturer, Sunovion Pharmaceuticals, to change its labels to reflect that. (Source: NYT Health)
Source: NYT Health - May 16, 2014 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Lunesta Drugs (Pharmaceuticals) Food and Drug Administration Source Type: news

FDA Halves Initial Dose for Lunesta (FREE)
By Kelly Young The FDA has recommended that the starting dose of the sleep drug eszopiclone (Lunesta) be lowered from 2 mg to 1 mg after a study found that patients taking higher doses … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 16, 2014 Category: Primary Care Source Type: news

FDA lowers starting dose for sleep medication Lunesta
Alex CukanWASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration said Thursday the manufacturer of Lunesta, or eszopiclone, must change the label to recommend a lower starting dose. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 15, 2014 Category: Consumer Health News Source Type: news

FDA Cuts Recommended Lunesta Dose
The FDA cut in half the recommended dose of the sleeping pill Lunesta, concluding some patients were impaired the morning after taking it even if they felt fully awake. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 15, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Slashes Starting Dose for Lunesta
(MedPage Today) -- SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 15, 2014 Category: Psychiatry Source Type: news

FDA halves Lunesta dose
Lunesta may help you doze off at night, but it's the morning after that has officials concerned -- which is why on Thursday they halved the recommended dosage for the well-known sleep aid drug. (Source: CNN.com - Health)
Source: CNN.com - Health - May 15, 2014 Category: Consumer Health News Source Type: news

FDA halves recommended Lunesta dose
Lunesta may help you doze off at night, but it's the morning after that has officials concerned -- which is why on Thursday they halved the recommended dosage for the well-known sleep aid drug. (Source: CNN.com - Health)
Source: CNN.com - Health - May 15, 2014 Category: Consumer Health News Source Type: news

Start Sleep Drug Lunesta at Lower Dose for Safety, FDA Says
Agency points to studies showing daytime drowsiness that could interfere with driving (Source: WebMD Health)
Source: WebMD Health - May 15, 2014 Category: Consumer Health News Source Type: news

Eszopiclone Containing Sleep Aids: Drug Safety Communication - Can Cause Next-Day Impairment
FDA recommends a decreased starting dose for both women and men. (Source: FDA MedWatch)
Source: FDA MedWatch - May 15, 2014 Category: American Health Source Type: news

FDA Cuts Starting Dose of Eszopiclone (Lunesta) in HalfFDA Cuts Starting Dose of Eszopiclone (Lunesta) in Half
The label change stems from new data on the risk for impaired alertness in some people the morning after use of the sleep aid. News Alerts (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 15, 2014 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news